BioSpace News Archive

Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company’s second quarter 2020 financial results and provide an operational update on Tuesday, August 4, 2020, at 7:30 a.m. ET.

Welltower Inc. (NYSE: WELL) today announced that it will release second quarter 2020 financial results after the close of trading on the New York Stock Exchange on Wednesday, August 5, 2020.

Aflac Incorporated announced that it will release second quarter financial results after the market closes on July 28, 2020. At that time, earnings materials, including the second quarter 2020 earnings release and Financial Analysts Briefing supplement, will be available on the company’s Investor Relations website, investors.aflac.com.

PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, will host a conference call on Wednesday, Aug. 5, 2020, at 8:30 a.m. (U.S. Eastern Time) to discuss its second quarter 2020 financial results.

Jaguar Health, Inc. (NASDAQ:JAGX) (''Jaguar’’ or the ''Company’’) today announced the voting results from the Special Meeting of Stockholders of the Company (the “Special Meeting”) that was held on July 21, 2020.

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, reported financial results for its first quarter ended June 27, 2020 of fiscal year 2021, which ends March 27, 2021.

Emergent BioSolutions Inc. (NYSE: EBS) today announced that Standard & Poor’s (S&P) has indicated that the company will be added to the S&P MidCap 400® index, effective prior to the open of trading on Friday, July 24.

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it is rescheduling the date of the Company’s Special Meeting of Stockholders (the “Special Meeting”) previously scheduled for Friday, June 26, 2020, to Friday, August 28, 2020, at 11:00 a.m., Eastern Time.

- Chugai and Biofourmis are partnering to develop a digital solution leveraging Biofourmis’ Biovitals® platform for pain management in patients with endometriosis - A non-interventional study will be conducted with endometriosis patients to validate the novel tool in real-life conditions